Bladder Cancer:
Painless Blood in the Urine, Treatment & Follow-Up Care

At a glance

How commonOne of the more common cancers; mainly affects older people, and men several times more often than women
DefinitionA malignant tumour of the bladder lining, in the vast majority of cases a urothelial carcinoma
Key symptomVisible blood in the urine without pain — often only from time to time
Main riskSmoking, as well as certain chemicals at work (aromatic amines)
TreatmentSuperficial: removal through the urethra, often plus bladder instillations (BCG); muscle-invasive: usually removal of the bladder with chemotherapy
Guideline & ICD-10German S3 guideline on bladder cancer (German Guideline Programme in Oncology) · C67 (carcinoma in situ: D09.0)

Bladder instillations, check-ups, medicines: keep track of it all

Instillation dates, supportive medicines and cystoscopies in one place — free in the brite app.

Create a treatment plan

1. What is bladder cancer?

Bladder cancer is a malignant tumour that starts in the inner lining of the bladder. This lining is called the urothelium; it also lines the renal pelvis, the ureters and the urethra. That is why by far the most common type is urothelial carcinoma. Bladder cancer mainly affects older people, and men develop it several times more often than women.¹,²

The typical first sign is blood in the urine that does not hurt. Because it often disappears on its own after a few days, it is easily dismissed. That is exactly what this article is about: painless does not mean harmless. How to make sense of reddish urine in general — from beetroot to kidney stones — is explained in the symptom article Blood in urine. Here the focus is on the disease itself: diagnosis, treatment and life afterwards.

The good news first. Most bladder tumours are discovered at a stage when they only affect the lining. They can then be removed through the urethra, and the bladder is preserved. The price is consistent follow-up care, because these tumours often come back.¹,³

2. Types and stages

For treatment and prognosis, one question matters above all: has the tumour grown into the muscle layer of the bladder wall or not?³

TypeWhat this meansTypical treatment
Non-muscle-invasive, papillary (Ta, T1)Grows into the bladder like a small cauliflower; Ta only in the lining, T1 into the connective tissue beneath itRemoval through the urethra (TURBT), bladder instillations depending on risk
Carcinoma in situ (CIS)A flat change in the lining that is hard to see, but aggressiveBCG instillations; if they fail, often removal of the bladder
Muscle-invasive (T2 and above)The tumour reaches into the bladder muscle or beyondRemoval of the bladder with chemotherapy, or bladder-sparing chemoradiotherapy
MetastaticSecondary tumours in lymph nodes, bones, lungs or liverSystemic treatment, for example an antibody-drug conjugate plus immunotherapy
Table scrolls to the right

In addition, the pathologist assesses the grade: “low grade” grows slowly and often comes back but rarely progresses; “high grade” is more aggressive. Stage, grade, size, the number of tumours and whether CIS is present together give a risk group (low, intermediate, high, very high), which determines follow-up treatment and the intervals between check-ups.³,⁴ Rare types such as squamous cell carcinoma or adenocarcinoma of the bladder are sometimes treated differently.


3. Symptoms: blood in the urine and other signs

  • Visible blood in the urine (macroscopic haematuria) — red, pink, brownish or with clots, usually without pain. It often appears only once or comes and goes.
  • Invisible blood (microscopic haematuria) — only shows up on a urine dipstick test or under the microscope.
  • Irritable bladder symptoms — more frequent urge to pass urine, burning when urinating, small amounts of urine. Typical above all of carcinoma in situ.
  • Signs of advanced stages — flank pain caused by a blocked ureter, bone pain, unintended weight loss, swollen legs.

Most of these symptoms have more harmless causes. The following table shows how common triggers differ — but it does not replace a medical assessment.¹

ObservationPossible causeAssessment
Blood in the urine, no pain, no feverBladder tumour, kidney tumour, prostateAlways have it checked by a urologist, even if it stops
Blood with burning and a frequent urge to pass urineUrinary tract infectionHave your urine tested; once it has healed, check that the blood has gone
Blood with colicky pain in the flank or groinKidney stonesSee a doctor; immediately if you have a fever
Blood in men with a weak streamEnlarged prostateA common cause, but a tumour still has to be ruled out
Red-orange or dark brown urine with no blood on the testFoods (beetroot) or medicinesHarmless if the dipstick shows no blood
Table scrolls to the right
Blood thinners do not explain blood in the urine. If you take apixaban, phenprocoumon or aspirin, you do bleed more easily — but often the anticoagulant merely reveals a cause that is there anyway. According to the guideline, blood in the urine is therefore investigated in exactly the same way in people on blood thinners. Do not stop the medicine on your own; contact your practice promptly instead. More in the guide Living with blood thinners.³

Conversely, some medicines colour the urine without any blood being present: for example nitrofurantoin (yellow-brown), metronidazole and levodopa (dark) or the tuberculosis medicine rifampicin (orange-red). A dipstick test at the practice quickly tells the difference.


4. Causes and risk factors

The kidneys excrete many harmful substances in the urine, which then sits in the bladder for hours. Cancer-causing substances therefore act directly on the lining. The most important risk factors:¹,³

  • Smoking — by far the most important factor. Smokers have a risk several times higher, and a large share of all bladder cancer cases can be traced back to tobacco. After stopping smoking, the risk falls again over the years.
  • Aromatic amines at work — in the past mainly in the dye, rubber, leather and textile industries, and also among painters or hairdressers with many years of contact with certain dyes. Bladder cancer caused by aromatic amines is recognised as an occupational disease in Germany (occupational disease no. 1301), often decades after the exposure.⁵
  • Age and sex — the risk rises markedly with age, and men are affected more often.
  • Previous radiotherapy to the pelvis — for example for prostate or womb cancer.
  • Chronic bladder inflammation — for example with a long-term catheter or with schistosomiasis (bilharzia), a tropical disease that is rare in Germany; above all, it favours squamous cell carcinomas.
Medicines as a risk factor. The cytotoxic drug cyclophosphamide can damage the bladder lining and increase the risk of bladder cancer; at high doses the bladder is protected with mesna. A slightly increased risk of bladder cancer has been observed with the diabetes medicine pioglitazone: according to the Summary of Product Characteristics, it must not be used in people with current or previous bladder cancer or with visible blood in the urine that has not been investigated. If you take pioglitazone and notice blood in your urine, discuss it with your doctor straight away — do not stop it on your own.⁶

In women, bladder cancer is on average discovered later, because blood in the urine is often first put down to cystitis or to their period. A “bladder infection” that does not clear up despite an antibiotic, or keeps coming back without any bacteria being found, therefore needs to be investigated more closely.¹


5. Diagnosis: from urine sample to cystoscopy

According to the guideline, any visible bleeding in the urine should be investigated by a urologist. Invisible blood is investigated depending on age and risk profile. There is no general screening for bladder cancer.³

  • Urine test: dipstick, microscopy and, if necessary, a urine culture to rule out an infection.
  • Ultrasound: of the bladder and kidneys, painless — but it misses small or flat tumours.
  • Cystoscopy: the decisive examination. A thin, flexible endoscope is passed through the urethra with anaesthetic gel; usually done as an outpatient in a few minutes.
  • Urine cytology: a search for tumour cells in the urine — helpful above all for aggressive and flat tumours.
  • TURBT: if something is found, the tumour is removed through the urethra under anaesthetic (transurethral resection). This is diagnosis and first treatment at the same time. For T1 or high-grade tumours, a second resection often follows a few weeks later.
  • Imaging: a CT scan with contrast (CT urography) checks the kidneys and ureters; with a muscle-invasive tumour, the chest and abdomen are also checked for secondary tumours.

To put it honestly: urine tests for so-called tumour markers are sometimes offered as self-pay services. According to the guideline, they cannot replace cystoscopy and are not suitable for early detection in people without symptoms.³ Before the TURBT, the team will discuss whether and when blood thinners are paused — that is for the treatment team to decide; see also Medications before surgery. For the first consultation, the guide Preparing for a doctor’s appointment will help.

6. Treatment of non-muscle-invasive bladder cancer

Around three quarters of bladder tumours are discovered at this stage. Treatment has two aims: to remove the tumour completely, and to prevent relapses and progression into the muscle layer. Which steps follow the TURBT depends on the risk group.³,⁴

Low risk TURBT and early instillation
Single chemotherapy instillation
Shortly after the TURBT, ideally within 24 hours, a cytotoxic drug such as mitomycin is put into the bladder for about one to two hours. It lowers the risk of relapse. Regular cystoscopies follow.
Intermediate risk Course of instillations
Chemotherapy or BCG instillations
A series of instillations over several months, either with a cytotoxic drug or with BCG. Which option is used depends on the tumour, how well you tolerate it and availability.
High risk BCG therapy or early removal of the bladder
BCG instillation
BCG consists of weakened tuberculosis bacteria that activate the immune system in the bladder wall against tumour cells. The usual approach is an induction course of six weekly instillations, followed by maintenance therapy for one to three years.
Radical cystectomy
If the risk is very high, or if the tumour comes back despite BCG, removal of the bladder is recommended before the cancer grows into the muscle.

To put it honestly: even with the best treatment, non-muscle-invasive tumours often come back — usually superficial again and readily treatable. That is why years of follow-up with cystoscopies are not a sign of mistrust but part of the treatment. Which option suits you is decided by the treatment team together with you; a second opinion before removal of the bladder is expressly your right.³

What happens during a BCG instillation. Drink little beforehand so that your bladder does not feel full. The solution is filled in through a thin catheter and should stay in the bladder for about two hours. In the hours afterwards, pass urine sitting down, clean the toilet as instructed by the practice and wash your hands and genital area thoroughly — BCG consists of live bacteria. Flu-like symptoms and burning when urinating for one or two days are common.⁷

7. Muscle-invasive bladder cancer: surgery, chemo, bladder preservation

If the tumour has grown into the muscle layer, removal through the urethra is no longer enough. Treatment belongs in an experienced centre and is planned at a tumour board.³

Standard Chemotherapy plus removal of the bladder
Neoadjuvant chemotherapy
Before the operation, suitable patients receive cisplatin-based combination chemotherapy; it improves the chances of cure. In some cases immunotherapy is added before and after the operation. Because of the strain it puts on the kidneys, cisplatin is not an option for everyone.
Radical cystectomy
Removal of the bladder together with the pelvic lymph nodes, in men usually with the prostate and seminal vesicles, in women often with the womb and parts of the vaginal wall. Urine is then drained through a urinary diversion.
Alternative Bladder-sparing treatment
Trimodal therapy
A TURBT that is as complete as possible, followed by radiotherapy combined with chemotherapy. Suitable for selected patients or for people who cannot have, or do not want, surgery. It requires close check-ups; if the cancer comes back, the bladder can still be removed.
Metastatic Systemic treatment
Enfortumab vedotin plus pembrolizumab
An antibody-drug conjugate together with an immune checkpoint inhibitor is now a standard first-line option. Alternatives are platinum-based chemotherapy with subsequent or concurrent immunotherapy and, for certain genetic changes (FGFR), targeted tablets.
Palliative care and pain medicine
Pain and symptom control should start early and in parallel, not only at the end. The aim is to gain time and quality of life; a cure is usually no longer possible at this stage.

8. Medicines, side effects and interactions

Depending on the stage, instillations, infusions, immunotherapy and many supportive medicines come together. What matters most:⁷

  • BCG and antibiotics: according to the Summary of Product Characteristics, BCG bacteria are sensitive to certain antibiotics, for example fluoroquinolones such as ciprofloxacin, doxycycline or gentamicin. Always check any new antibiotic with the urology team during the BCG phase. If you have an acute urinary tract infection, the instillation is postponed.
  • BCG and the immune system: if you take immunosuppressants, higher-dose cortisone or biologics, you may not be able to have BCG — disclose all your long-term medicines beforehand. For vaccinations around the time of treatment, see Vaccines and medications.
  • Cisplatin: can damage the kidneys, hearing and nerves; as a precaution you are given plenty of fluids and anti-sickness medicines, for example ondansetron — on a fixed schedule, not only once symptoms appear. Painkillers such as ibuprofen or diclofenac put additional strain on the kidneys.
  • Enfortumab vedotin: typical effects are skin reactions, tingling in the hands and feet (polyneuropathy), dry eyes and raised blood sugar levels — with diabetes, your levels are monitored more closely.
  • Immune checkpoint inhibitors: can trigger inflammation in almost any organ, for example the thyroid, bowel, lungs or skin — even weeks after the last dose.
When to call straight away. A high fever after a BCG instillation that does not settle or lasts longer than about two days, shivering fits or feeling seriously unwell can point to a BCG infection and must be treated immediately. Likewise, a fever during chemotherapy, severe skin reactions, persistent diarrhoea or sudden breathlessness on immunotherapy need the hospital straight away — at night via the emergency department or 112 (emergency number in Germany). Do not leave out prescribed supportive medicines on your own; see Stopping medications.

Interactions are hard to keep track of with cancer treatments, especially as many of those affected are older and already take several long-term medicines. So always raise St John’s wort, high-dose supplements and any new over-the-counter preparations beforehand; the guide Drug interactions is a good place to start. The choice and dose of every medicine is decided by the treatment team.

Instillation dates and supportive medicines on schedule

brite reminds you of instillations, anti-sickness tablets and check-up appointments.

Set up a reminder

9. Living with a urostomy or neobladder

After removal of the bladder, urine needs a new route out. Which urinary diversion is an option depends on the extent of the tumour, kidney function, age and your own wishes. A thorough consultation before the operation, including with a stoma nurse, is important.³

Urinary diversionPrincipleIn everyday life
Ileal conduit (urostomy)A short piece of small intestine carries the urine out through an opening in the abdominal wallUrine drains continuously into a bag; technically simpler, fewer metabolic effects
NeobladderA replacement bladder is formed from small intestine and connected to the urethraPassing urine the natural way; requires bladder training, sometimes self-catheterisation
Continent pouchA reservoir made from bowel with a valve is emptied with a catheter through a small opening at the navelNo bag, but regular catheterisation
Table scrolls to the right
  • Train the neobladder — at first, empty it by the clock, at night too with an alarm, and slowly lengthen the intervals. Wetting at night is common in the first few months and often improves.
  • Monitor your metabolism — the bowel lining in the replacement bladder absorbs salts from the urine. Over-acidification of the blood is detected with blood gas tests and sometimes corrected with sodium bicarbonate.
  • Think about vitamin B12 — if the end of the small intestine is missing, vitamin B12 deficiency can develop over the years. Regular checks are part of follow-up care.
  • Keep an eye on your kidneys — narrowing of the ureters or recurrent infections can put a strain on the kidneys; see chronic kidney disease.
  • Talk about sex — after the operation, erection problems are common in men, and pain during intercourse in women. Help is available; more under erectile dysfunction.

10. Follow-up care and everyday life

Follow-up care depends on the risk group. With non-muscle-invasive bladder cancer, cystoscopies are at the centre — every few months in the first years, less often later, and for life if the risk is high. After a cystectomy, imaging, kidney function and blood tests are added.³,⁴

  • Stopping smoking is worth it now too — smoking is associated with more frequent relapses. Medical support, nicotine replacement or stop-smoking programmes markedly increase the chances of success compared with quitting on your own.
  • Always report blood in the urine — between two check-ups as well. After a TURBT a little blood is normal for a few days; clots or being unable to pass urine are not.
  • Have an occupational disease checked — if you had contact with dyes, rubber or tar products at work, the practice can report a suspected occupational disease. This can lead to financial benefits.
  • Drink enough — sensible for the kidneys and a replacement bladder. However, there is no evidence that drinking a lot prevents relapses.
  • Accept support — inpatient rehabilitation after hospital, stoma care, continence training, psycho-oncological counselling and self-help groups are all part of care.

Many people with bladder cancer are older and already take medicines for high blood pressure, diabetes or heart rhythm disorders. Over the years, check-ups, instillations and new medicines are added. An up-to-date medication plan and a list of all appointments are then not bureaucracy but safety.

Cystoscopies and results over time

Record check-up dates, results and symptoms and take everything with you to your next follow-up appointment.

Track your follow-up

FAQ: Common questions about bladder cancer

No. More common causes are urinary tract infections, kidney stones or an enlarged prostate. But painless blood in the urine in particular is the typical first sign of bladder cancer and should therefore always be checked by a urologist, even if it disappears again after a few days.
The most important examination is cystoscopy, in which a thin endoscope is passed through the urethra into the bladder. This is combined with a urine test, an ultrasound scan and, if necessary, urine cytology. The diagnosis is confirmed by removing the tumour and examining the tissue under the microscope.
In early, non-muscle-invasive stages the outlook is good, although the tumours often come back and need many years of follow-up care. Muscle-invasive bladder cancer can also be cured with chemotherapy and surgery or with chemoradiotherapy, but the chances are lower. When there are metastases, the focus is usually on extending life.
Weakened tuberculosis bacteria are filled into the bladder through a catheter. There they trigger an immune response that fights tumour cells and reduces relapses. The usual course is six weekly instillations followed by maintenance therapy for one to three years.
Smoking is the most important risk factor for bladder cancer and increases the risk several times over. The harmful substances are excreted via the kidneys and act directly on the bladder lining through the urine. Stopping smoking lowers the risk over the years and is worthwhile even after the diagnosis, because it makes relapses less frequent.
No. Most tumours are discovered at an early stage and can be removed through the urethra. Removal of the bladder is mainly necessary if the tumour has grown into the muscle or if a high-risk tumour comes back despite BCG. For selected patients, bladder-sparing chemoradiotherapy is also an option.
No. Blood thinners do increase the tendency to bleed, but they often merely reveal a cause that is there anyway. Blood in the urine is therefore investigated in exactly the same way in people on anticoagulants. Do not stop the medicine on your own; contact your practice promptly instead.

Sources

  1. German Cancer Information Service of the German Cancer Research Centre (DKFZ): Bladder cancer — German source. Accessed 2026. krebsinformationsdienst.de
  2. Robert Koch Institute, German Centre for Cancer Registry Data: Bladder cancer. Accessed 2026. krebsdaten.de
  3. German S3 guideline on the early detection, diagnosis, treatment and follow-up of bladder cancer, German Guideline Programme in Oncology (AWMF, German Cancer Society, German Cancer Aid), AWMF register number 032-038OL, version 3.0, 2025 — German source. leitlinienprogramm-onkologie.de
  4. European Association of Urology (EAU): Guidelines on Non-muscle-invasive Bladder Cancer, 2025 edition. uroweb.org
  5. German Ordinance on Occupational Diseases (BKV), Annex 1, occupational disease no. 1301: mucosal changes, cancer or other neoplasms of the urinary tract caused by aromatic amines; information sheet of the Federal Institute for Occupational Safety and Health (BAuA) — German source. Accessed 2026. baua.de
  6. Summaries of Product Characteristics for pioglitazone and cyclophosphamide (sections on contraindications and warnings) — German source. Accessed 2026. fachinfo.de
  7. Summaries of Product Characteristics for BCG for intravesical use, cisplatin and enfortumab vedotin (sections on administration, warnings, interactions and side effects) — German source. Accessed 2026. fachinfo.de

Instillations, check-ups, medicines — under control with brite

Dose reminders, interaction checks, your results over time. Free.

Get started now
brite App
Medical disclaimer: This article is for general information and does not replace medical advice, diagnosis or treatment. Visible blood in the urine should always be checked by a urologist, even if it stops on its own or you take blood thinners; a persistent fever after a BCG instillation or a fever during chemotherapy is an emergency. The choice of medicine and its dose is always decided individually by the treating practice. Last updated: November 2026.